Prestige Consumer Healthcare (PBH) Competitors $74.72 -0.43 (-0.57%) As of 01:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, SNN, and BIOShould you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estee Lauder Companies (EL), Smith & Nephew SNATS (SNN), and Bio-Rad Laboratories (BIO). Prestige Consumer Healthcare vs. Its Competitors Interparfums Herbalife USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Medifast Veru Estee Lauder Companies Smith & Nephew SNATS Bio-Rad Laboratories Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends. Which has higher valuation & earnings, PBH or IPAR? Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Consumer Healthcare$1.14B3.25$214.60M$4.2917.42Interparfums$1.45B2.95$164.36M$5.1425.97 Is PBH or IPAR more profitable? Prestige Consumer Healthcare has a net margin of 18.86% compared to Interparfums' net margin of 11.30%. Interparfums' return on equity of 17.62% beat Prestige Consumer Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Prestige Consumer Healthcare18.86% 12.87% 6.78% Interparfums 11.30%17.62%11.86% Does the media refer more to PBH or IPAR? In the previous week, Interparfums had 2 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 8 mentions for Interparfums and 6 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.76 beat Interparfums' score of 1.39 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Interparfums 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, PBH or IPAR? Prestige Consumer Healthcare has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500. Do insiders & institutionals hold more shares of PBH or IPAR? 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 1.4% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 43.9% of Interparfums shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend PBH or IPAR? Prestige Consumer Healthcare currently has a consensus price target of $93.33, suggesting a potential upside of 24.91%. Interparfums has a consensus price target of $162.00, suggesting a potential upside of 21.36%. Given Prestige Consumer Healthcare's higher probable upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than Interparfums.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Consumer Healthcare 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Interparfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryInterparfums beats Prestige Consumer Healthcare on 10 of the 16 factors compared between the two stocks. Get Prestige Consumer Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBH vs. The Competition Export to ExcelMetricPrestige Consumer HealthcareMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.69B$10.19B$5.56B$20.60BDividend YieldN/A2.09%4.23%3.65%P/E Ratio17.4216.9728.6127.20Price / Sales3.2528.48437.4953.52Price / Cash14.6622.6736.0222.28Price / Book2.023.608.184.58Net Income$214.60M$233.40M$3.23B$995.22M7 Day Performance-5.21%-2.88%-0.25%-1.09%1 Month Performance-10.69%1.60%5.40%3.25%1 Year Performance4.07%-19.42%26.35%6.97% Prestige Consumer Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBHPrestige Consumer Healthcare4.4002 of 5 stars$74.72-0.6%$93.33+24.9%+6.2%$3.69B$1.14B17.42540News CoveragePositive NewsIPARInterparfums4.2011 of 5 stars$136.05-1.8%$157.60+15.8%+5.0%$4.45B$1.45B26.47530News CoveragePositive NewsHLFHerbalife4.252 of 5 stars$9.65-3.3%$11.50+19.2%-17.7%$1.02B$4.95B3.528,600USNAUSANA Health Sciences4.4864 of 5 stars$32.14-1.9%$36.00+12.0%-30.7%$610.28M$854.50M17.661,700Upcoming EarningsNUSNu Skin Enterprises2.8156 of 5 stars$8.91-0.1%$6.88-22.8%-17.7%$440.76M$1.68B-11.143,100Positive NewsNATRNature's Sunshine Products2.0374 of 5 stars$16.02+2.8%$18.33+14.4%-5.1%$287.84M$454.36M30.23850Positive NewsHigh Trading VolumeMEDMedifast3.6474 of 5 stars$14.62+0.3%$16.50+12.9%-26.3%$160.25M$602.46M-22.49870VERUVeru2.8563 of 5 stars$0.58-3.8%$4.00+585.4%-39.0%$88.92M$16.89M-2.43230Positive NewsELEstee Lauder Companies4.0557 of 5 stars$85.82-3.3%$74.45-13.2%-14.9%$31.92B$15.61B-35.4662,000Trending NewsAnalyst ForecastSNNSmith & Nephew SNATS2.8871 of 5 stars$29.95-1.1%$28.00-6.5%+5.9%$13.26B$5.81B13.8717,349BIOBio-Rad Laboratories4.6798 of 5 stars$247.45-1.6%$324.25+31.0%-18.1%$6.85B$2.54B-3.257,700News CoverageAnalyst DowngradeAnalyst Revision Related Companies and Tools Related Companies IPAR Competitors HLF Competitors USNA Competitors NUS Competitors NATR Competitors MED Competitors VERU Competitors EL Competitors SNN Competitors BIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PBH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
